ORMP - ORAMED PHARMACEUTICALS INC.
2.25
-0.040 -1.778%
Share volume: 57,636
Last Updated: 05-09-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$2.29
-0.04
-0.02%
Summary score
24%
Profitability
0%
Dept financing
12%
Liquidity
50%
Performance
45%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2015 - 30-Sep-2019
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-14.55%
Return on assets
-8.13%
Return on sales
-617.32%
Return on invested capital
-33.01%
Total debt ratio
44.05%
Debt ratio change over timeo
0%
Current Ratio
5.67%
Quick Ratio
0%
Cash Position Ratio
0.67%
Short-term ratios 30-Sep-2018 - 30-Sep-2019
The data are presented for the financials results of the quarters of the last year.
Return on equity
-15.04%
Return on assets
-9.21%
Return on sales
-612.08%
Return on invested capital
-27.75%
Total debt ratio
39.91%
Debt ratio change over timeo
0%
Current Ratio
6.07%
Quick Ratio
0%
Cash Position Ratio
0.75%
Last quarter ratios 30-Sep-2019
The data are presented for the financials results of the last quarter.
Return on equity
-11.76%
Return on assets
-6.77%
Return on sales
0%
Return on invested capital
57.45%
Total debt ratio
44.05%
Debt ratio change over time
0%
Current Ratio
6.28%
Quick Ratio
0%
Cash Position Ratio
0.63%
Performance ratios (change over 4 years) 30-Sep-2015 - 30-Sep-2019
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ORMP | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | -14.55% | 10.78% | 4.09% | 20.46% |
| Return on assets | -8.13% | 3.26% | 3.42% | 11.82% |
| Return on sales | -617.32% | 23.28% | 26.47% | 42.55% |
| Return on invested capital | -33.01% | 4.09% | 4.02% | -313.95% |
| Profitability | 0% | 59% | 52% | 75% |
| Total debt ratio | 44.05% | 73.53% | 56.89% | 53.75% |
| Debt ratio change over time | 0% | 0% | 8.85% | 0% |
| Dept financing | 15% | 25% | 44% | 18% |
| Current Ratio | 6.07% | 1.29% | 1.38% | 1.02% |
| Quick Ratio | 0% | 1% | 1.09% | 0.73% |
| Cash Position Ratio | 0.75% | 0.3% | 0.54% | 0.25% |
| Liquididy | 50% | 39% | 55% | 32% |
| Short-term ratios | ORMP | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | -15.04% | 29.72% | 5.92% | 19.04% |
| Return on assets | -9.21% | 3.64% | 3.4% | 10.97% |
| Return on sales | -612.08% | 25.5% | 25.5% | 42.41% |
| Return on invested capital | -27.75% | 8.1% | 4.48% | -59.59% |
| Profitability | 0% | 73% | 42% | 66% |
| Total debt ratio | 39.91% | 88.74% | 61.26% | 55.71% |
| Debt ratio change over time | 0% | 0% | 11.4% | 0% |
| Dept financing | 11% | 25% | 42% | 16% |
| Current Ratio | 6.07% | 1.29% | 1.38% | 1.02% |
| Quick Ratio | 0% | 1% | 1.09% | 0.73% |
| Cash Position Ratio | 0.75% | 0.3% | 0.54% | 0.25% |
| Liquididy | 50% | 38% | 49% | 29% |
